Major bourses in Asia were in the green on Tuesday, tracking a rally on Wall Street after the FDA granted full approval to the Pfizer/BioNTech COVID-19 vaccine. Meantime, worries of imminent tapering by the Fed eased after US private sector growth slowed to an 8-month low in August. Investors’ attention now turns to the Jackson Hole Symposium later in the week. The Hang Seng and the Shanghai Composite led the gains, jumping 2% and 1.1%, each, on signs that the current outbreak in China may be waning amid Beijing’s zero-tolerance stance and tough anti-virus measures across the country. Stocks in South Korea rose for the 2nd session, buoyed by strong gains in tech stocks. Meantime, the Nikkei 225 climbed 0.9% to trade at a near two-week high. Shares in Australia edged up 0.2%, increasing for the second session in a row.
